Jazz Pharmaceuticals plc — Director's Dealing 2016

Aug 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-08-16

Reporting Person: Treacy Paul (SVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-16	Ordinary Shares	S	1287.0	$137.468	Disposed	13875	Direct
2016-08-16	Ordinary Shares	S	5.0	$137.46	Disposed	13870	Direct

Footnotes

F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F2: Includes 62 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2016.